Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.

Journal Article (Journal Article)

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. This selection for the journal focuses on metastatic (known as extensive-stage) SCLC, which is more common than limited-stage SCLC. Systemic therapy alone can palliate symptoms and prolong survival in most patients with extensive-stage disease. Smoking cessation counseling and intervention should be strongly promoted in patients with SCLC and other high-grade neuroendocrine carcinomas. The "Summary of the Guidelines Updates" section in the SCLC algorithm outlines the most recent revisions for the 2022 update, which are described in greater detail in this revised Discussion text.

Full Text

Duke Authors

Cited Authors

  • Ganti, AKP; Loo, BW; Bassetti, M; Blakely, C; Chiang, A; D'Amico, TA; D'Avella, C; Dowlati, A; Downey, RJ; Edelman, M; Florsheim, C; Gold, KA; Goldman, JW; Grecula, JC; Hann, C; Iams, W; Iyengar, P; Kelly, K; Khalil, M; Koczywas, M; Merritt, RE; Mohindra, N; Molina, J; Moran, C; Pokharel, S; Puri, S; Qin, A; Rusthoven, C; Sands, J; Santana-Davila, R; Shafique, M; Waqar, SN; Gregory, KM; Hughes, M

Published Date

  • December 2021

Published In

Volume / Issue

  • 19 / 12

Start / End Page

  • 1441 - 1464

PubMed ID

  • 34902832

Pubmed Central ID

  • PMC10203822

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2021.0058


  • eng

Conference Location

  • United States